Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Post by austrochrison Mar 16, 2021 3:19am
372 Views
Post# 32805549

very good news !!

very good news !!they have created the subsidry, Amphotericin B Technologies, Inc., that means its an entity of its own and they are looking for several partnerships. this is way bigger than just a drug now. its a platform. They must have amazing numbers otherwise why would they create the subsidry. also they have cleared human trials with oral ampB ICO-019 phase 1a and 1b. this is way more advanced than animal studies
( from ceo,ca )
<< Previous
Bullboard Posts
Next >>